Engineered TfR-Binding Polypeptides for Blood-Brain Barrier Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to effectively deliver therapeutic agents across the blood-brain barrier (BBB) for treating brain disorders and diseases due to the barrier's restrictive nature.
Innovation Solution
Engineering polypeptides with modified CH2 and CH3 domains that bind to the transferrin receptor (TfR), allowing transport of therapeutic agents across the BBB by leveraging the natural TfR-mediated transcytosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the blood-brain barrier is maintained in its natural restrictive state, then brain protection is achieved, but therapeutic agent delivery to the brain is blocked
Solution Approach 1:
The patent uses transferrin receptor-binding polypeptides as intermediary carriers that exploit the natural TfR-mediated transcytosis pathway. These polypeptides bind to TfR on the blood-brain barrier endothelium and facilitate transport of therapeutic agents across the barrier without compromising the barrier's protective function. The intermediary acts as a shuttle that temporarily engages with the barrier's transport mechanism to deliver cargo.
Solution Approach 2:
The invention leverages the blood-brain barrier's own transcytosis mechanism for iron delivery (a natural function of TfR) to serve the dual purpose of both physiological iron import and therapeutic agent delivery. The system uses the barrier's inherent transport capability rather than overcoming it, allowing the barrier to service itself while enabling drug delivery.
2Productivity
If polypeptides are engineered with multiple substitutions to enhance TfR binding, then brain uptake efficiency is improved, but polypeptide complexity increases
Solution Approach 1:
The patent systematically modifies specific amino acid parameters at defined positions within the CH2 and CH3 domains to optimize TfR binding affinity and brain uptake efficiency. By changing discrete parameters (amino acid identities at specific positions) rather than redesigning the entire polypeptide structure, the invention achieves enhanced productivity with controlled complexity increment.
Solution Approach 2:
The engineering efforts are focused on specific local regions (CH2 and CH3 domains) rather than uniform modification throughout the entire polypeptide. This localized quality enhancement allows targeted improvement of binding interfaces while preserving the overall structural simplicity and functional integrity of the polypeptide.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances brain uptake of therapeutic agents, providing a viable method for treating disorders and diseases where brain delivery is advantageous.
Implementation Method 1
TfR naturally moves transferrin from the blood into the brain. Because these polypeptides bind TfR, they too can be transported across the BBB
Data Source
AI summary
Provided herein are polypeptides that bind to a transferrin receptor, methods of generating such polypeptides, and methods of using the polypeptides to target a composition to a transferrin receptor-expressing cell.